|
CMDX is focused on the development and commercialization of DNA-based diagnostic products and services using gene expression profiling (GEP), comparative genomic hybridization (CGH), and single nucleotide polymorphism (SNP) technologies.
We are organized into three business units:
Diagnostic Testing Services
We have built a state-of-the-art molecular diagnostics clinical laboratory in Irvine, California and soon will begin offering genomic testing services in the area of cancer diagnostics.
Clinical Trials
To help realize the potential of the burgeoning science known as “personalized medicine”, we are partnering with pharmaceutical companies to identify patients who stand to receive the greatest benefit from currently available drugs, as well as those under development.
Manufacturing
CMDX sells custom CGH microarrays and reagents to researchers worldwide.
|